Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 44 percent decrease over losses of $(0.25) per share from the same period last year.
Related Posts
Earnings Preview: Fastenal
Fastenal (NASDAQ:FAST) is set to give its latest quarterly earnings report on Thursday, 2024-01-18. Here’s what investors need…
Shiba Inu Governance Token Gains 7% Amid Dogecoin Weakness
Bone ShibaSwap (CRYPTO: BONE), the governance token of the ShibaSwap ecosystem, is up 7% in the last 24 hours, even as top meme coins such as Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO:
What’s Going On With Nvidia Stock Thursday
Nvidia Corp (NASDAQ: NVDA) stock continues to pique investor interest despite risks to its crucial market as the U.S. eyes a stricter stance over China's AI ambitions.